European Federation of Pharmaceutical Industries and Associations

The European Federation of Pharmaceutical Industries and Associations or EFPIA is the organization representing the research-based pharmaceutical industry operating in Europe. The EFPIA was created in 1978. [ [http://www.medicalnewstoday.com/articles/112414.php "30 Years Contributing To The Health And Wealth Of EU Citizens"] , Medical News Today, 23 June 2008. Consulted on July 26, 2008. ]

The EFPIA has a direct membership of 30 national pharmaceutical industry associations and in addition 45 individual pharmaceutical companies. The EFPIA as such represents 2,100 research-based pharmaceutical companies in Europe.

Some of the EFPIA members are: Abbott Laboratories,
Akzo Nobel,
Almirall,
Amgen,
AstraZeneca,
Baxter International,
Bayer Healthcare,
Boehringer Ingelheim,
Bristol-Myers Squibb,
Chiesi Farmaceutici,
Eli Lilly and Company,
Ēzai,
Esteve,
Genzyme,
Gilead Science,
GlaxoSmithKline,
Grünenthal,
Ipsen Group,
Johnson & Johnson,
Lundbeck,
Menarini,
Merck KGaA,
Merck & Co., Inc.,
Novartis,
Novo Nordisk,
Nycomed,
Orion Oyj,
Pfizer,
Laboratoires Pierre Fabre,
Procter & Gamble,
Hoffmann-La Roche,
sanofi-aventis,
Schering-Plough,
Servier,
Sigma-Tau,
Solvay,
Takeda Pharmaceutical Company,
UCB S.A. and
Wyeth.

In May 2008 EFPIA together with the European Commission [ [http://imi.europa.eu/index_en.html "European Union describes IMI"] ] launched the Innovative Medicines Initiative [ [http://www.imi-europe.org/Pages/default.aspx "Innovative Medicines Initiative"] ] (IMI) Joint Undertaking (JU) to strengthen the position of Europe in pharmaceutical research. The aim of IMI is to support the faster discovery and development of better medicines for patients and to enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic high-technology sector. The JU was initiated based on the positive experience in joint research activities during the InnoMed [ [http://imi.europa.eu/docs/press-release-30042008_en.pdf "By joining resources Europe and the pharmaceutical industry gain the lead"] ] Integrated Project, a pilot funded under the European Commission’s Sixth Framework Programme, with the two sub-projects InnoMed AddNeuroMed and InnoMed PredTox [ [http://www.innomed-predtox.com/ "InnoMed PredTox"] ] .

References

See also

* European and Developing Countries Clinical Trials Partnership (EDCTP)
* EuropaBio
* FlandersBio
* European Federation of Biotechnology (EFB)
* European Pharmaceutical Union
* International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
* Japan Pharmaceutical Manufacturers Association (JPMA)
* List of pharmaceutical manufacturers in the United Kingdom
* Pharmaceutical Research and Manufacturers of America (PhRMA)
* Pharmaceutical company

External links

* [http://www.efpia.org/ European Federation of Pharmaceutical Industries and Associations]
* [http://www.imi-europe.org/Pages/default.aspx Innovative Medicines Initiative]
* [http://www.innomed-predtox.com/ InnoMed PredTox]